Postmenopausal vaginal atrophy and atrophic vaginitis

Area of Science:

• Gynecology
• Urology
• Geriatric Medicine

Background:

• Menopause significantly decreases estrogen production, impacting female lower urinary tract health.
• Reduced estrogen causes vaginal atrophy, leading to discomfort, dyspareunia, and inflammation.
• Estrogen deficiency affects periurethral tissues, potentially causing pelvic laxity and stress incontinence.

Purpose of the Study:

• To review the effects of estrogen reduction on the female lower urinary tract.
• To explore the link between vaginal changes and urinary symptoms post-menopause.
• To identify the need for further research on optimal estrogen replacement therapy in geriatric females.

Main Methods:

• Literature review of studies on menopause, estrogen, and lower urinary tract symptoms.
• Analysis of the impact of estrogen on vaginal and urethral tissues.
• Examination of current understanding of estrogen replacement therapy efficacy and dosage.

Main Results:

• Estrogen reduction leads to vaginal atrophy, inflammation, and altered pH, contributing to dyspareunia and urinary symptoms.
• Urinary symptoms include frequency, urgency, dysuria, and incontinence, exacerbated by diminished estrogen.
• Changes in vaginal flora increase susceptibility to urinary tract infections in postmenopausal women.

Conclusions:

• Estrogen deficiency significantly affects the lower urinary tract and vaginal health in postmenopausal women.
• Estrogen replacement therapy can improve vaginal epithelium maturation and alleviate symptoms.
• Further research is needed to determine optimal estrogen therapy forms and dosages for geriatric women's quality of life.